M14-702
ClinicalTrials.gov NCT03213457
Research payments
$10,265,440
Through program year 2020, $10,265,440 in research payments was reported against M14-702, across 3,796 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03213457
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $3,378,258 | 1,663 |
| 2019 | Research | $6,887,182 | 2,133 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Janet Dittus Nashville, TN Named on 125 payments
- Clark Griffith Dallas, TX Named on 112 payments
- Arthur Waldbaum Denver, CO Named on 76 payments
- John Partridge Richmond, VA Named on 64 payments
- Gregory Moore Richmond, VA Named on 60 payments
- Paul Miller Greenville, SC Named on 52 payments
- Richard Zane Alpharetta, GA Named on 49 payments
- Angelina Gangestad Cleveland, OH Named on 43 payments
- Valentin Almendarez San Antonio, TX Named on 43 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.